Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12052585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Placenta percreta is a rare but potentially lethal condition. Previously described conservative measures to avoid life-threatening hemorrhage and preserve fertility include use of methotrexate and uterine artery embolization. A woman with suspected placenta percreta diagnosed on ultrasound in the second trimester was delivered by classic, fundal cesarean at 30 weeks' gestation for bleeding and premature rupture of membranes. The placenta was left in situ, and she was treated with methotrexate. Postpartum bleeding 1 week later was managed by internal iliac balloon catheterization and manual transcervical removal of the placenta, which resulted in hysterectomy and required massive blood transfusion. Placenta percreta managed conservatively with methotrexate and internal iliac balloon catheterization resulted in serious morbidity.
Medical subject headings
- Abortifacient Agents, Nonsteroidal
- Catheterization
- Methotrexate
- Placenta Accreta
- Postpartum Hemorrhage